Letrozole


Curated chemical-gene interactions from CTD
Entrez gene IDGene symbolInteraction typeReference
10135 NAMPT Increases expression PMID:32298659
1026 CDKN1A Increases expression PMID:20054642
114548 NLRP3 Increases expression PMID:37328115
133 ADM Increases expression PMID:33491863
1490 CCN2 Increases expression PMID:33491863
1543 CYP1A1 Increases expression PMID:39032681
1583 CYP11A1 Decreases expression PMID:37030623
1586 CYP17A1 Affects expression PMID:32298659; PMID:37030623; PMID:37254606
1588 CYP19A1 Affects activity PMID:15837728; PMID:15909811; PMID:16009161; PMID:16013988; PMID:16023854; PMID:16033851; PMID:16034487; PMID:16046582; PMID:16054421; PMID:16480277; PMID:17145897; PMID:21341743; PMID:24496634; PMID:29501854; PMID:30817981; PMID:32197950; PMID:15967659; PMID:20087668; PMID:24902786
1588 CYP19A1 Decreases expression PMID:37030623
1595 CYP51A1 Decreases activity PMID:16989930
16333 INS1 Increases expression PMID:28619389; PMID:33359182; PMID:33491863; PMID:37030623
1649 DDIT3 Increases expression PMID:33491863
17311 KITL Decreases expression PMID:37030623
1978 EIF4EBP1 Decreases activity PMID:16033851
2002 ELK1 Increases expression PMID:15967659
207 AKT1 Decreases expression PMID:33491863
2099 ESR1 Decreases expression PMID:37030623
22926 ATF6 Increases expression PMID:33491863
22943 DKK1 Increases expression PMID:21851939
2488 FSHB Affects expression PMID:15123030; PMID:33491863; PMID:37030623
2492 FSHR Decreases expression PMID:37030623
2678 GGT1 Increases activity PMID:37328115
2697 GJA1 Decreases expression PMID:29180066
27006 FGF22 Increases expression PMID:21851939
2885 GRB2 Increases expression PMID:15967659
2936 GSR Decreases expression PMID:31295448
3162 HMOX1 Decreases expression PMID:28619389
3292 HSD17B1 Increases expression PMID:39032681
3569 IL6 Increases expression PMID:33359182; PMID:33491863
3586 IL10 Increases expression PMID:28619389
367 AR Decreases expression PMID:37030623
36957 LHR Decreases expression PMID:37030623
3939 LDHA Increases activity PMID:37328115
3972 LHB Increases expression PMID:15123030; PMID:16046582; PMID:28619389; PMID:33491863; PMID:39032681; PMID:37030623
3976 LIF Increases expression PMID:21851939
3977 LIFR Increases expression PMID:21851939
4288 MKI67 Decreases expression PMID:16002280
4780 NFE2L2 Decreases expression PMID:28619389
5241 PGR Decreases expression PMID:16002280
5294 PIK3CG Decreases expression PMID:33491863
5468 PPARG Decreases expression PMID:33491863
5594 MAPK1 Increases expression PMID:15967659
5595 MAPK3 Increases expression PMID:15967659
5604 MAP2K1 Increases expression PMID:15967659
5605 MAP2K2 Increases expression PMID:15967659
5617 PRL Increases expression PMID:33359182
56729 RETN Increases expression PMID:32298659
581 BAX Increases expression PMID:33491863; PMID:39032681
5894 RAF1 Increases expression PMID:15967659
5925 RB1 Affects activity PMID:16033851
595 CCND1 Decreases expression PMID:16033851
596 BCL2 Decreases expression PMID:33491863; PMID:39032681
6195 RPS6KA1 Increases expression PMID:15967659
6464 SHC1 Increases expression PMID:15967659
6517 SLC2A4 Decreases expression PMID:32298659
6770 STAR Increases expression PMID:39032681
7040 TGFB1 Increases expression PMID:28619389; PMID:33491863
7124 TNF Increases expression PMID:28619389; PMID:33359182; PMID:33491863
7422 VEGFA Increases expression PMID:37030623
7494 XBP1 Increases expression PMID:33491863
847 CAT Decreases activity PMID:37030623
894 CCND2 Decreases expression PMID:16033851
9370 ADIPOQ Decreases expression PMID:33359182

DISCLAIMER

We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.